Amphivena Therapeutics Inc.

📍 South San Francisco, United States🗓 Founded 2012👥 15 employees💰 Last funded Dec 2018
Biotechnology🌐 amphivena.com
Website LinkedIn
Amphivena Therapeutics Inc is a privately held immuno-oncology company based in SSF, that is developing selective T cell engagers for treatment of hematological and solid tumors. AMV564, our lead molecule, has demonstrated novel clinical activity in rapidly and selectively eliminating leukemic blasts in AML and granulocytic/monocytic MDSCs while sparing normal myeloid cells, providing a unique opportunity to explore the impact of depleting MDSCs in cancers.
3
Total investors
0
Early stage
1
Mid stage
2
Late stage
2012
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2015–2018 · investors recorded per year
2015120182
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Amphivena Therapeutics Inc.?
Amphivena Therapeutics Inc. has 3 investors on record on gritt.io, 1 mid-stage and 2 late-stage investors.
When did Amphivena Therapeutics Inc. last raise funding?
The most recent investment in Amphivena Therapeutics Inc. recorded on gritt.io was in December 2018.
When was Amphivena Therapeutics Inc. founded?
Amphivena Therapeutics Inc. was founded in 2012.
What industry is Amphivena Therapeutics Inc. in?
Amphivena Therapeutics Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Amphivena Therapeutics Inc. based?
Amphivena Therapeutics Inc. is headquartered in South San Francisco, United States.